2018
DOI: 10.1016/j.msec.2017.04.038
|View full text |Cite
|
Sign up to set email alerts
|

Bone regeneration: Biomaterials as local delivery systems with improved osteoinductive properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
90
0
6

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 133 publications
(96 citation statements)
references
References 59 publications
0
90
0
6
Order By: Relevance
“…Biologically inspired biomaterials have been developed based on the functionalization of implant surfaces and bioengineered scaffolds with ECM‐derived biomolecules. Different types of osteoconductive biomaterials, such as hydroxyapatite (HA), calcium phosphates (CaPs), and bioactive glasses (BGs) have been shown to enable the nucleation and growth of CaP crystals both in vitro and in vivo (Martin & Bettencourt, ). Among these, BGs possess comparatively higher bioactivity than HA and CaPs, owing to their high surface reactivity and their ionic dissolution products in aqueous environments (Ciraldo, Boccardi, Melli, Westhauser, & Boccaccini, ).…”
Section: Introductionmentioning
confidence: 99%
“…Biologically inspired biomaterials have been developed based on the functionalization of implant surfaces and bioengineered scaffolds with ECM‐derived biomolecules. Different types of osteoconductive biomaterials, such as hydroxyapatite (HA), calcium phosphates (CaPs), and bioactive glasses (BGs) have been shown to enable the nucleation and growth of CaP crystals both in vitro and in vivo (Martin & Bettencourt, ). Among these, BGs possess comparatively higher bioactivity than HA and CaPs, owing to their high surface reactivity and their ionic dissolution products in aqueous environments (Ciraldo, Boccardi, Melli, Westhauser, & Boccaccini, ).…”
Section: Introductionmentioning
confidence: 99%
“…Autografting is the gold standard currently used to treat bone defects. However, this treatment has many limitations, including limited bone mass, donor site complications, and bone resorption . Allografting is another primary treatment option but is limited by infection and immune rejection .…”
Section: Introductionmentioning
confidence: 99%
“…More than 2.2. million bone grafting procedures are performed annually worldwide to repair bone defects in orthopaedics, neurosurgery and dentistry (Giannoudis et al ., ; Ginebra et al ., ). This is even more important due to the expected ageing society and the increase in activity up to older age, meaning that the number of patients undergoing these procedures will raise, as well as the associated costs in treating those patients (Martin & Bettencourt, ; Winkler et al ., ). Despite the profound clinical and economic impact, treatments of bone defects remain controversial, especially when the defect is critical sized (Schemitsch, ; Nauth et al ., ).…”
Section: Introductionmentioning
confidence: 99%